tiprankstipranks
Virax Biolabs (NASDAQ: VRAX) Soars After Launch of Monkeyvirus Test Kit
Market News

Virax Biolabs (NASDAQ: VRAX) Soars After Launch of Monkeyvirus Test Kit

Shares of Virax Biolabs (NASDAQ: VRAX) soared in pre-market trading on Tuesday as the diagnostics company focused on the detection and diagnosis of viral diseases announced the distribution of a Virus Antigen Rapid Test Kits for monkey virus. The company has launched this kit in markets “accepting the CE mark, such as the European Union.”

The kit will help healthcare professionals to accurately identify people suspected of carrying the monkeypox virus as the results will be available in 15 minutes.

James Foster, Chairman, and CEO of Virax Biolabs commented, “I am very proud of our organization’s ability to quickly bring this rapid antigen test kit to market to help combat the monkeypox outbreak. We are working diligently to distribute the kits as well as the previously announced Monkeypox and Varicella Zoster Viruses Real Time PCR Detection Kits into the hands of healthcare practitioners as quickly as possible.”

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles